4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-005417
CEO and Chairman sold 33,360 shares at an average $30.71 ($1,024,586)
- CEO and Chairman acquired 33,360 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-27 | Exercise or conversion : show line 1 in the form | +11,120 | $0.33 | $3,670 | 1,889,300 | D |
| 2020-01-27 | Sale : show line 2 in the form | −11,120 | $30.01 | $333,711 | 1,878,180 | D |
| 2020-01-28 | Exercise or conversion : show line 3 in the form | +11,120 | $0.33 | $3,670 | 1,889,300 | D |
| 2020-01-28 | Sale : show line 4 in the form | −10,320 | $31.08 | $320,746 | 1,878,980 | D |
| 2020-01-28 | Sale : show line 5 in the form | −800 | $31.90 | $25,520 | 1,878,180 | D |
| 2020-01-29 | Exercise or conversion : show line 6 in the form | +11,120 | $0.33 | $3,670 | 1,889,300 | D |
| 2020-01-29 | Sale : show line 7 in the form | −11,120 | $30.99 | $344,609 | 1,878,180 | D |
| Open-market sales · 33,360 sh · avg $30.71 · $1,024,586 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-01-27 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −11,120 | 768,800 | D |
| 2020-01-28 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −11,120 | 757,600 | D |
| 2020-01-29 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −11,120 | 746,400 | D |
Loading xslF345X03/doc4.xml…